PATENTS OFFICE JOURNAL - Irish Patents Office

(26/07/2006) Patents Office Journal (No. 2051) 1681
Supplementary Protection Certificates Rejected
The name and address of the requestor follow the number allocated to the request. The date in brackets,
following the name and address, is the date of receipt of the request. The patent number is that under which
the product in respect of which a certificate is sought is, allegedly, protected. Market authorisation references
in respect of the product concerned are also shown.
2000/023 G. D. SEARLE & CO
P.O. Box 5110, Chicago, Il 60680-5110, United States of America
(10 November 2000)
Patent No. 0731795
Product:
Substituted pyrazolyl benzenesulfonamides for the treatment of
inflammation
Celecoxib, optionally in the form of a pharmaceutically acceptable
salt thereof
Market Authorisation: Ireland PA 778/20/1-2 and 778/21/1-2
(12 May 2000)
Sweden 15431-15434 and 14838-14841
(03 December 1999)
Application rejected under Article 10(4) of Council Regulation (EEC) No. 1768/92
2002/018 YEDA RESEARCH AND DEVELOPMENT CO. LTD.
P.O. Box 95, Rehovot 76110, Israel
(06 August 2002)
Patent No. 0762888
Product:
Copolymer-1 improvements in compositions of copolymers
Copaxone
Market Authorisation: Ireland PA 1014/1/1
(07 September 2001)
UK PL 10921/0019
(09 August 2000)
Application rejected under Article 10(4) of Council Regulation (EEC) No. 1768/92
2002/031 GILEAD SCIENCES, INC.
353 Lakeside Drive, Foster City, CA 94404, United States of America
(07 November 2002)
Patent No. 0759917
Product:
Novel selective inhibitors of viral or bacterial neuraminidases
Oseltamivir or a pharmaceutically acceptable salt thereof, especially
oseltamivir phosphate
Market Authorisation: Ireland EU/1/02/222/001-002
(20 June 2002)
Application rejected under Article 10(4) of Council Regulation (EEC) No. 1768/92